Pure Global

The Vitality Mammography Messaging Study - Trial NCT06277141

Access comprehensive clinical trial information for NCT06277141 through Pure Global AI's free database. This phase not specified trial is sponsored by Wits Health Consortium (Pty) Ltd and is currently Recruitment Completed. The study focuses on Breast Cancer Female. Target enrollment is 6665 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06277141
Recruitment Completed
behavioral
Trial Details
ClinicalTrials.gov • NCT06277141
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Vitality Mammography Messaging Study
The Vitality Mammography Study - Testing the Effectiveness of a Booking Platform on Receipt of Screening Mammography - a Randomized Controlled Trial.

Study Focus

Breast Cancer Female

Standard message

Interventional

behavioral

Sponsor & Location

Wits Health Consortium (Pty) Ltd

Johannesburg, South Africa

Timeline & Enrollment

N/A

Sep 27, 2023

Mar 31, 2024

6665 participants

Primary Outcome

Comparison of mammography screening rates using WhatsApp

Summary

The investigators will be conducting a randomized controlled trial amongst members of a
 Wellness Program to test receipt of mammogram using the Whatsapp social media platform and
 testing various messages.

ICD-10 Classifications

Malignant neoplasm: Breast, unspecified
Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Personal history of malignant neoplasm of breast

Data Source

ClinicalTrials.gov

NCT06277141

Non-Device Trial